Rimm D - Search Results

1

"Lineage addiction" in human cancer: lessons from integrated genomics.

Garraway LA, Weir BA, Zhao X, Widlund H, Beroukhim R, Berger A, Rimm D, Rubin MA, Fisher DE, Meyerson ML, Sellers WR. Garraway LA, et al. Among authors: rimm d. Cold Spring Harb Symp Quant Biol. 2005;70:25-34. doi: 10.1101/sqb.2005.70.016. Cold Spring Harb Symp Quant Biol. 2005. PMID: 16869735

2

Quantitative determination of expression of the prostate cancer protein alpha-methylacyl-CoA racemase using automated quantitative analysis (AQUA): a novel paradigm for automated and continuous biomarker measurements.

Rubin MA, Zerkowski MP, Camp RL, Kuefer R, Hofer MD, Chinnaiyan AM, Rimm DL. Rubin MA, et al. Among authors: rimm dl. Am J Pathol. 2004 Mar;164(3):831-40. doi: 10.1016/s0002-9440(10)63171-9. Am J Pathol. 2004. PMID: 14982837 Free PMC article.

3

Her2/neu is not a commonly expressed therapeutic target in melanoma -- a large cohort tissue microarray study.

Kluger HM, DiVito K, Berger AJ, Halaban R, Ariyan S, Camp RL, Rimm DL. Kluger HM, et al. Melanoma Res. 2004 Jun;14(3):207-10. doi: 10.1097/01.cmr.0000130874.33504.2f. Melanoma Res. 2004. PMID: 15179190

4

alphaB-crystallin as a marker of lymph node involvement in breast carcinoma.

Chelouche-Lev D, Kluger HM, Berger AJ, Rimm DL, Price JE. Chelouche-Lev D, et al. Among authors: rimm dl. Cancer. 2004 Jun 15;100(12):2543-8. doi: 10.1002/cncr.20304. Cancer. 2004. PMID: 15197794 Free article.

5

Integrative genomic analyses identify MITF as a lineage survival oncogene amplified in malignant melanoma.

Garraway LA, Widlund HR, Rubin MA, Getz G, Berger AJ, Ramaswamy S, Beroukhim R, Milner DA, Granter SR, Du J, Lee C, Wagner SN, Li C, Golub TR, Rimm DL, Meyerson ML, Fisher DE, Sellers WR. Garraway LA, et al. Nature. 2005 Jul 7;436(7047):117-22. doi: 10.1038/nature03664. Nature. 2005. PMID: 16001072 Free article.

6

Automated quantitative analysis of activator protein-2alpha subcellular expression in melanoma tissue microarrays correlates with survival prediction.

Berger AJ, Davis DW, Tellez C, Prieto VG, Gershenwald JE, Johnson MM, Rimm DL, Bar-Eli M. Berger AJ, et al. Cancer Res. 2005 Dec 1;65(23):11185-92. doi: 10.1158/0008-5472.CAN-05-2300. Cancer Res. 2005. PMID: 16322269

7

Immunohistochemistry and quantitative analysis of protein expression.

Cregger M, Berger AJ, Rimm DL. Cregger M, et al. Arch Pathol Lab Med. 2006 Jul;130(7):1026-30. doi: 10.5858/2006-130-1026-IAQAOP. Arch Pathol Lab Med. 2006. PMID: 16831029 Free article. Review.

8

GOLPH3 modulates mTOR signalling and rapamycin sensitivity in cancer.

Scott KL, Kabbarah O, Liang MC, Ivanova E, Anagnostou V, Wu J, Dhakal S, Wu M, Chen S, Feinberg T, Huang J, Saci A, Widlund HR, Fisher DE, Xiao Y, Rimm DL, Protopopov A, Wong KK, Chin L. Scott KL, et al. Nature. 2009 Jun 25;459(7250):1085-90. doi: 10.1038/nature08109. Nature. 2009. PMID: 19553991 Free PMC article.

9

Subcellular localization of activating transcription factor 2 in melanoma specimens predicts patient survival.

Berger AJ, Kluger HM, Li N, Kielhorn E, Halaban R, Ronai Z, Rimm DL. Berger AJ, et al. Cancer Res. 2003 Dec 1;63(23):8103-7. Cancer Res. 2003. PMID: 14678960

10

Automated quantitative analysis of HDM2 expression in malignant melanoma shows association with early-stage disease and improved outcome.

Berger AJ, Camp RL, Divito KA, Kluger HM, Halaban R, Rimm DL. Berger AJ, et al. Cancer Res. 2004 Dec 1;64(23):8767-72. doi: 10.1158/0008-5472.CAN-04-1384. Cancer Res. 2004. PMID: 15574789

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

543 results

Search Page

Filters